Royalty Pharma plc (RPRX)
NASDAQ·Healthcare·Biotechnology
$54.96
-0.54%
Mkt Cap $23.60B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
Implied Upside
-6.8%
Consensus $51.25 vs current $54.96
NASDAQ·Healthcare·Biotechnology
$54.96
-0.54%
Mkt Cap $23.60B
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
-6.8%
Consensus $51.25 vs current $54.96